Adma Biologics, Inc.
ADMA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001368514
No open-market purchases or sales by Adma Biologics, Inc. insiders were filed in the last 90 days; 322 institutions reported holding it in 13F filings for Q2 2026, worth $1.70B in total; superinvestors Duquesne Family Office and Fundsmith hold it.
13F holders, Q2 2022
Institutional positions in Adma Biologics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 113
- +9 vs. Q1 2022
- Shares held
- 119.2M
- +14.3M (+13.7%) vs. Q1 2022
- Total value
- $236.0M
- +$46.2M (+24.3%) vs. Q1 2022
- New holders
- 35
- 31 more added
- Sold out
- 26
- 26 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADMA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 322 | $1.70B |
| Q1 2026 | 358 | $1.91B |
| Q4 2025 | 357 | $4.02B |
| Q3 2025 | 366 | $3.28B |
| Q2 2025 | 369 | $3.84B |
| Q1 2025 | 347 | $4.07B |
| Q4 2024 | 321 | $3.50B |
| Q3 2024 | 306 | $4.16B |
| Q2 2024 | 253 | $2.03B |
| Q1 2024 | 214 | $1.16B |
| Q4 2023 | 184 | $764.6M |
| Q3 2023 | 188 | $612.7M |
| Q2 2023 | 179 | $610.6M |
| Q1 2023 | 163 | $547.2M |
| Q4 2022 | 160 | $592.2M |
| Q3 2022 | 130 | $315.4M |
| Q2 2022 | 113 | $236.0M |
| Q1 2022 | 105 | $189.9M |
| Q4 2021 | 88 | $137.1M |
| Q3 2021 | 72 | $47.3M |
| Q2 2021 | 90 | $68.6M |
| Q1 2021 | 104 | $85.4M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Adma Biologics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Altium Capital Management LP | 4,000,000 | $7.92M | 3.35% | +700,000+21.2% | Added |
| D. E. Shaw & Co., Inc. | 4,832,392 | $9.57M | 0.02% | +2,930,104+154.0% | Added |
| AWM Investment Company, Inc. | 5,015,000 | $9.93M | 1.56% | +335,000+7.2% | Added |
| Millennium Management LLC | 5,889,971 | $11.7M | 0.02% | +2,531,272+75.4% | Added |
| Velan Capital Investment Management LP | 6,073,598 | $12.0M | 12.75% | +250,800+4.3% | Added |
| Magnetar Financial LLC | 6,860,872 | $13.6M | 0.16% | +351,955+5.4% | Added |
| Stonepine Capital Management, LLC | 7,000,000 | $13.9M | 6.45% | −131,808−1.8% | Reduced |
| Nuveen Asset Management, LLC | 7,162,189 | $14.2M | 0.01% | −432,751−5.7% | Reduced |
| Vanguard Group Inc | 9,040,244 | $17.9M | 0.00% | +901,824+11.1% | Added |
| Boothbay Fund Management, LLC | 10,360,400 | $20.5M | 0.71% | −47,859−0.5% | Reduced |
| Perceptive Advisors LLC | 11,521,102 | $22.8M | 0.72% | −412,285−3.5% | Reduced |
| BlackRock Inc. | 12,590,726 | $24.9M | 0.00% | +8,483,344+206.5% | Added |
| Mackenzie Financial Corp | 12,753 | – | – | +12,753 | New |
| Bank of Montreal | 0 | $0 | 0.00% | −910,000−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −317,542−100.0% | Sold out |
| Parian Global Management LP | 0 | $0 | 0.00% | −315,000−100.0% | Sold out |
| 683 Capital Management, LLC | 0 | $0 | 0.00% | −222,603−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −185,654−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −179,996−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −148,080−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −143,115−100.0% | Sold out |
| Mirabella Financial Services LLP | 0 | $0 | 0.00% | −101,510−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −91,717−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −71,400−100.0% | Sold out |
| Sciencast Management LP | 0 | $0 | 0.00% | −60,583−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −48,328−100.0% | Sold out |
| Old Mission Capital LLC | 0 | $0 | 0.00% | −34,907−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −34,900−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −31,968−100.0% | Sold out |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −26,010−100.0% | Sold out |
| Shay Capital LLC | 0 | $0 | 0.00% | −23,504−100.0% | Sold out |
| Beacon Pointe Advisors, LLC | 0 | $0 | 0.00% | −23,490−100.0% | Sold out |
| CTC Capital Management, LLC | 0 | $0 | 0.00% | −17,600−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −11,954−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −11,395−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,184−100.0% | Sold out |
| Private Advisor Group, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Ovata Capital Management Ltd | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Exane Derivatives | 0 | $0 | 0.00% | −1,299−100.0% | Sold out |
| Livingston Group Asset Management CO (operating as Southport Capital Management) | – | – | – | – | Not filed |